1. Home
  2. SME IPO
  • Sunrest Lifescience Ltd IPO
Sunrest Lifescience IPO

Sunrest Lifescience IPO

  • Status: Closed
  • RHP:
  • ₹ 134,400 / 1600 shares

    Minimum Investment

IPO Details

  • Open Date

    07 Nov 2023

  • Close Date

    09 Nov 2023

  • IPO Price Range

    ₹ 84

  • IPO Size

    ₹ 10.85 Cr

  • Listing Exchange

    NSE SME

  • Listing Date

    20 Nov 2023

With just a few clicks, Invest in IPOs!

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Objective Financials SWOT FAQ Contacts

IPO Timeline

Sunrest Lifescience IPO Subscription Status

Last Updated: 03 January 2024 8:57 PM by 5Paisa

Sunrest Lifescience Limited IPO is all set to open from 7th November to 9th November 2023. The company is engaged in the business of healthcare and personal care products. The IPO includes a fresh issue of 1,291,200 shares worth ₹10.85 cr. The share allotment date is 15th November, and the IPO will be listed on 20th November on the stock exchanges. The price is ₹84 per share and the lot size is 1600 shares.    

Mark Corporate Advisors Private Limited is the book-running lead manager for this IPO, while Skyline Financial Services Private Limited is the registrar. 

Objectives of Sunrest Lifescience IPO:

Sunrest Lifescience Limited plans to utilize the raised capital from the IPO to:

●    For working capital.
●    General corporate purposes.
●    To fund the public issue expense.

Established in 2017, Sunrest Lifescience Limited is engaged in the business of healthcare and personal care products. The company gets its product range manufactured by third parties and markets them. Sunrest Lifescience sells its products to  Super Stockists and Stockists which is later made available to Hospitals, Chemist shops, Dispensaries, and more. The company possesses in total 18 Registered Trademarks for 32 products. 

Its range of products includes Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Additionally, the company’s portfolio includes drugs such as  Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.

Sunrest Lifescience’s operations are spread in Gujarat, Maharashtra, Madhya Pradesh, Orissa and Rajasthan. 

Peer Comparison
●    Vaishali Pharma Limited
●    Chandra Bhagat Pharma Limited
 

For More Information:
Webstory on Sunrest Lifescience IPO
Sunrest Lifescience IPO GMP

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY22 FY21
Revenue from operations (interest income) 24.26 26.89 16.95
EBITDA 2.93 1.12 0.27
PAT 2.04 0.78 0.17
Particulars (in Rs. Crores) FY23 FY22 FY21
Total Assets 16.71 13.02 9.48
Share Capital 3.00 0.01 0.01
Total Borrowings 13.59 11.95 9.19
Particulars (in Rs. Crores) FY23 FY22 FY21
Net cash generated from / (used in) operating activities 1.15 -0.45 0.15 
Net cash from / (used in) investing activities -0.030 -0.36 -0.16
Net cash flow from / (used in) financing activities -1.15 0.91 0.038
Net increase (decrease) in cash and cash equivalents -0.031 0.11 0.0296


Strengths

1.    The company offers a wide range of products. 
2.    It also has an efficient marketing team which is crucial for the business. 
3.    The company’s Board and Senior Management are experienced. 
4.    Planning to expand its local presence. 
 

Risks

1.    The company relies on third parties for manufacturing products.
2.    Significant working capital requirements. 
3.    Operate in a highly regulated and controlled industry environment.
4.    Negative cash flows in the past.
5.    Subject to fluctuations in the prices of raw materials. 
 

Will You Apply for Sunrest Lifescience IPO?

Yes No Maybe

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
footer_form

FAQs

The minimum lot size of Sunrest Lifescience IPO is 1600 shares and the investment required is ₹1,34,400.

The price for Sunrest Lifescience IPO is ₹84 per share. 

Sunrest Lifescience IPO opens from 7th November to 9th November 2023.
 

The size of Sunrest Lifescience IPO is ₹10.85 cr. 

The share allotment date of Sunrest Lifescience IPO is 15th November 2023.

The Sunrest Lifescience IPO will be listed on 20th November 2023.

Mark Corporate Advisors Private Limited is the book-running lead manager for Sunrest Lifescience IPO.

Sunrest Lifescience Limited plans to utilize the raised capital from the IPO to:

1.    For working capital.
2.    General corporate purposes.
3.    To fund the public issue expense.
 

To apply for Sunrest Lifescience IPO, follow the steps given below:

●    Login to your 5paisa account and select the issue in the current IPO section    
●    Enter the number of lots and the price at which you wish to apply for the Sunrest Lifescience Limited IPO.    
●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.    
●    You will receive a mandate notification to block funds in your UPI app.